Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -18.118% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CC1CCCCN1C(=O)CCNC(=O)Cn1cnc2ccccc2c1=O
(b) CC1c2cccn2CCN1CC(O)COCC1=CCC2CC1C2(C)C
(c) Cn1c(=O)n(C)c2cc(S(=O)(=O)Nc3cc(Cl)ccc3O)ccc21
Answer: b. CC1c2cccn2CCN1CC(O)COCC1=CCC2CC1C2(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1c2cccn2CCN1CC(O)COCC1=CCC2CC1C2(C)C
CC1c2cccn2CCN1CC(O)COCC1=CCC2CC1C2(C)C
1-[(6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl)methoxy]-3-(1-methyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)propan-2-ol